Ayala Pharmaceuticals Encaminhar P/E
Qual é o Encaminhar P/E de Ayala Pharmaceuticals?
O Encaminhar P/E de Ayala Pharmaceuticals Inc. é -0.14
Qual é a definição de Encaminhar P/E?
A razão entre preço e lucro a termo é a razão entre o preço das ações da empresa e o lucro estimado por ação da empresa para os próximos doze meses.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Encaminhar P/E de empresas na Setor Health Care em NASDAQ em comparação com Ayala Pharmaceuticals
O que Ayala Pharmaceuticals faz?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Empresas com encaminhar p/e semelhantes a Ayala Pharmaceuticals
- Frequency Therapeutics Inc tem Encaminhar P/E de -0.18
- Titan Medical tem Encaminhar P/E de -0.17
- Tenax Therapeutics Inc tem Encaminhar P/E de -0.16
- Corbus Pharmaceuticals Inc tem Encaminhar P/E de -0.15
- BioXcel Therapeutics Inc tem Encaminhar P/E de -0.15
- Ontrak Inc tem Encaminhar P/E de -0.14
- Ayala Pharmaceuticals tem Encaminhar P/E de -0.14
- Digital Ally tem Encaminhar P/E de -0.13
- Lannett Co tem Encaminhar P/E de -0.11
- EVIO tem Encaminhar P/E de -0.11
- Arcadia Biosciences Inc tem Encaminhar P/E de -0.11
- Reliance Communications tem Encaminhar P/E de -0.10
- Rubius Therapeutics Inc tem Encaminhar P/E de -0.09